#biotech stocks — FinScans

📈 Stocks

Biogen Stock Plunges as Tau-Targeting Alzheimer's Therapy Misses Trial Endpoints

July 14, 2026 (1 day ago)

Biogen's stock tumbled as its tau-directed Alzheimer's candidate disappointed in clinical testing, stoking concerns over the drugmaker's pipeline durability and potentially reshaping…

BIIB

🌍 US Read More →

📈 Stocks

UniQure Soars as FDA Clears Huntington’s Therapy for US Filing

June 17, 2026 (28 days ago)

UniQure stock pops following FDA’s reversal allowing Huntington’s disease therapy AMT-130 to move toward US approval filing.

QURE

🌍 US Read More →

📈 Stocks

Confirmed screwworm case in Texas lifts Zoetis, options volume surges

June 4, 2026 (41 days ago)

Zoetis options trading surged as a confirmed Texas screwworm case fueled bets on animal health stocks benefiting from increased disease treatment demand.

ZTS

🌍 US Read More →

📈 Stocks

Molecular Glue Deals Surpass $1 Billion, Cementing Cancer Drug Breakthrough

May 29, 2026 (47 days ago)

Billion-dollar molecular glue deals reshape the cancer drug landscape, driving biotech valuations and pharma licensing activity to new highs.

GLUE IBB

🌍 US Read More →